Opinion
Oral GLP-1 agonists could be game changers for obesity
- Author:
- Kevin Fernando, MBChB, MSc
Publish date: July 6, 2023
I hope that future developments bring the class to an even wider demographic and perhaps reduce some of the global inequities in managing type 2...
Opinion
Tirzepatide: Therapeutic titan or costly cure?
- Author:
- Kevin Fernando, MBChB, MSc
Publish date: June 29, 2023
Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an...